A novel davunetide (NAPVSIPQQ to NAPVSIPQE) point mutation in activity-dependent neuroprotective protein (ADNP) causes a mild developmental syndrome

Medicine & Life Sciences

• davunetide 100%
• Point Mutation 52%
• Proteins 19%
• Microtubules 19%
• Static Electricity 17%
• Mutation 10%
• Carrier Proteins 8%
• src Homology Domains 5%
• Muscle Hypotonia 5%
• Clustered Regularly Interspaced Short Palindromic Repeats 5%
• Missense Mutation 5%
• Cytoskeleton 4%
• Names 4%
• Intellectual Disability 4%
• Computer Simulation 4%
• Fear 4%
• Binding Sites 3%
• Eating 3%
• Ligands 3%
• Genome 3%
• Inflammation 2%
• Child 2%
• Pharmaceutical Preparations 2%
• Therapeutics 0%